https://biotechmorning.com/news/eli-lilly-cuts-off-hospitals-340b-discounts Biotech Morning en 2026-06-24T14:25:25.078Z Eli Lilly Just Cut Off 50 Hospital Systems. The Reason Will Surprise You. https://biotechmorning.com/news/sangamo-gene-editing-pioneer-sold-for-parts Biotech Morning en 2026-06-24T14:24:37.621Z Gene Editing's Original Pioneer Just Got Sold for Parts https://biotechmorning.com/news/biogen-apellis-acquisition-complement-platform Biotech Morning en 2026-06-24T14:23:50.396Z Biogen Just Spent $5.6 Billion on a Comeback Story https://biotechmorning.com/news/china-car-t-solid-tumor-approval Biotech Morning en 2026-06-24T14:22:58.756Z China Just Cracked the Code That CAR-T Couldn't https://biotechmorning.com/news/jnj-firefly-bio-billion-dollar-acquisition Biotech Morning en 2026-06-24T14:22:07.024Z J&J Just Paid $1 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/serapha-bio-230m-series-a-gene-editing-china Biotech Morning en 2026-06-24T14:21:14.459Z A $230M Bet on a Gene Editor Born in China https://biotechmorning.com/news/ollin-330m-bet-dethrone-roche-eye-drug Biotech Morning en 2026-06-24T14:20:18.151Z The $330M Bet to Dethrone Roche's Eye Drug Empire https://biotechmorning.com/news/lilly-abbisko-1-9-billion-shanghai-collaboration Biotech Morning en 2026-06-24T14:19:20.196Z Lilly Keeps Going Back to the Same Shanghai Lab. Here's Why. https://biotechmorning.com/news/servier-edgewise-muscular-dystrophy-deal Biotech Morning en 2026-06-24T14:18:29.322Z Servier Just Dropped $2.65 Billion on a Drug That Doesn't Exist Yet https://biotechmorning.com/news/eli-lilly-centessa-sleep-disorders-acquisition Biotech Morning en 2026-06-24T14:17:31.378Z Eli Lilly Just Spent $6.3 Billion to Fix a Problem You Didn't Know It Had https://biotechmorning.com/news/merck-6-7-billion-terns-pharmaceuticals-cml-2 Biotech Morning en 2026-06-24T14:16:35.597Z Merck Just Spent $6.7 Billion on a Drug Most People Have Never Heard Of https://biotechmorning.com/news/ai-designed-drug-crosses-human-brain Biotech Morning en 2026-06-23T14:27:02.041Z The AI-Designed Drug That Just Crossed Into the Human Brain https://biotechmorning.com/news/cancer-treatment-on-body-injector-uk-approval Biotech Morning en 2026-06-23T14:26:17.473Z Cancer Treatment Just Left the Hospital Building https://biotechmorning.com/news/merck-calderasib-keytruda-kras-lung-cancer-breakthrough Biotech Morning en 2026-06-23T14:25:29.254Z Merck Found a Way to Make Keytruda Even Better at Killing Lung Cancer https://biotechmorning.com/news/pfizer-seagen-adc-lung-cancer-phase-3-failure Biotech Morning en 2026-06-23T14:24:42.126Z Pfizer Spent $43 Billion on Seagen. Its First Big Test Just Flopped. https://biotechmorning.com/news/first-disease-modifying-therapy-childhood-type-1-diabetes Biotech Morning en 2026-06-23T14:23:59.095Z The Drug That Tells Type 1 Diabetes to Wait https://biotechmorning.com/news/cemdisiran-quarterly-shot-myasthenia-gravis-fda-priority-review Biotech Morning en 2026-06-23T14:23:12.561Z The Shot You Take Once a Quarter That Could Reshape Myasthenia Gravis https://biotechmorning.com/news/exelixis-zanzalintinib-colorectal-cancer-endpoint-miss Biotech Morning en 2026-06-23T14:22:22.014Z Exelixis Built a Backup Plan for Its $2B Drug. It Just Hit a Wall. https://biotechmorning.com/news/fda-operation-trailblazer-phase-1-acceleration Biotech Morning en 2026-06-23T14:21:35.367Z The FDA Just Found 12 Months Hiding in Its Own Paperwork https://biotechmorning.com/news/merck-tulisokibart-phase-3-ulcerative-colitis-results Biotech Morning en 2026-06-23T14:20:48.553Z Merck's $10.8 Billion Bet on Gut Health Just Passed Its Biggest Test https://biotechmorning.com/news/fda-real-time-clinical-trials-astrazeneca-amgen-2 Biotech Morning en 2026-06-23T14:19:59.365Z The FDA Wants to Watch Your Clinical Trial Live. Like, Right Now.